Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3H)‑ones as Potential Antileukemic Agents

Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3H)‑ones as Potential Antileukemic Agents

Saved in:

Bibliographic Details
Main Authors:	Giorgio Antoniolli, Keli Lima, Gilberto Carlos Franchi, Carmen Silvia Passos Lima, João Agostinho Machado-Neto, Fernando Coelho
Format:	Article
Language:	English
Published:	American Chemical Society 2025-08-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c04106
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SYNTHETIC QUINAZOLINONES AS NEW ANTILEUKEMIC AGENTS
by: Giorgio Antoniolli, et al.
Published: (2025-05-01)

NEW FUNCTIONALIZED QUINAZOLINES AS POTENTIAL AGENTS AGAINST HEAD AND NECK AND LUNG CANCER
by: Giorgio Antoniolli, et al.
Published: (2025-05-01)

Synthesis and Antimicrobial Activity of Some Novel Substituted Piperazinyl-quinazolin-3(4H)-ones
by: N. M. Raghavendra, et al.
Published: (2008-01-01)

Cardioprotective activity and screening of N-substituted of quinazolin-4(3Н)-ones
by: O. V. Dzhyhaliuk, et al.
Published: (2019-02-01)

Deciphering Steroidal and Aporphine Alkaloids as Antileukemic Agents by Approaches of Molecular Networking and Metabolomics
by: Suni Liu, et al.
Published: (2025-03-01)

A Systematic Review of Synthetic and Anticancer and Antimicrobial Activity of Quinazoline/Quinazolin‐4‐one Analogues
by: Neha Manhas, et al.
Published: (2025-07-01)

Synthesis and Antibacterial Activity of 3-(Substituted)-2-(4-oxo-2-phenylquinazolin-3(4H)-ylamino)quinazolin-4(3H)-one
by: Ramgopal Appani, et al.
Published: (2016-01-01)

Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment
by: Meri A. Shervashidze, et al.
Published: (2023-08-01)

Experimental pharmacological research regarding some new quinazolin-4-ones derivatives
by: Cornel Chiriță, et al.
Published: (2019-05-01)

Phytochemical Investigation of Egyptian Riverhemp: A Potential Source of Antileukemic Metabolites
by: Shimaa M. Abdelgawad, et al.
Published: (2022-01-01)

6-Amino-7-((4-methoxybenzyl)thio)quinazolin-4(3<i>H</i>)-one
by: Susila Thapa, et al.
Published: (2024-12-01)

Antileukemic Activity of 1-Oxyphenazine Produced by Pseudomonas Aureofaciens Phz 127/11
by: I. N. FEKLISTOVA, et al.
Published: (2014-07-01)

Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
by: Lu Liu, et al.
Published: (2024-12-01)

Antileukemic Activity of 1-Oxyphenazine Produced by Pseudomonas Aureofaciens Phz 127/11
by: I. N. FEKLISTOVA, et al.
Published: (2016-07-01)

ANTIMICROBIAL ACTIVITY STUDY OF NEW QUINAZOLIN-4(3H)-ONES AGAINST STAPHYLOCOCCUS AUREUS AND STREPTOCOCCUS PNEUMONIAE
by: M. A. Samotrueva, et al.
Published: (2021-09-01)

Novel Thiazole-Fused [4,5-<i>g</i>] or [5,4-<i>g</i>]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation
by: Nathan Broudic, et al.
Published: (2024-10-01)

Quinazoline scaffold as a target for combating microbial resistance: Synthesis and antimicrobial profiling of quinazoline derivatives
by: Vishwanath Halappanavar, et al.
Published: (2025-01-01)

Synthesis of N3-substituted-quinazoline-2,4(1H,3H)-diones via CuI-catalyzed coupling of 2-iodobenzamides with potassium cyanate
by: Ali Nasirpour, et al.
Published: (2025-05-01)

Synthesis and Antitumor Activity of 6‑(2-Aminobenzo[d]thiazol-5-yl) quinazolin-4(3H)‑one Derivatives
by: Ailing Linghu, et al.
Published: (2025-02-01)

Influence of allogeneic mesenchymal stem cells on leukemic cells <i>in vitro</i> sensitivity to antileukemic drugs
by: O. S. Tatarinova, et al.
Published: (2022-11-01)

Investigation of actoprotective activity in a range of 6-N-R-tetrazolo[1,5-c]quinazolin-5(6H)-ones
by: O. M. Antypenko, et al.
Published: (2016-01-01)

Substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines - a promising class of lipoxygenase inhibitors
by: V. V. Stavytskyi, et al.
Published: (2020-05-01)

Synthesis and biological evaluation of some novel benzoxazin-4-one and quinazolin-4-one derivatives based on anti-inflammatory commercial drugs
by: Shah Alam Khan, et al.
Published: (2024-04-01)

Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
by: Yaping Chang, et al.
Published: (2021-01-01)

Direct CH/CH functionalization of 1,3-dihydroxy-9H-xanthen-9-one and 1,3-dimethoxy-9H-xanthen-9-one with 1,2,4-triazines and quinazoline
by: A. D. Sharapov, et al.
Published: (2020-12-01)

Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity
by: Adel A.-H. Abdel-Rahman, et al.
Published: (2024-10-01)

PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an In Vitro Antileukemic Immune Response
by: Sara Trabanelli, et al.
Published: (2015-01-01)

The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
by: Jin Shouwen, et al.
Published: (2023-08-01)

Assessment of Acute Toxicity of Quinazoline Derivative 3-[2-oxo-2-(4-Phenylpiperazine-1-yl)Ethyl]quinazoline-4(3h)-oh Active against Opportunistic Microorganisms
by: N. M. Gabitova, et al.
Published: (2023-07-01)

New derivatives of quinazoline alkaloids: synthesis and biological activity
by: Zubenko A.A., et al.
Published: (2025-04-01)

New pathways for the synthesis of indolyl-containing quinazoline trifluoroacetohydrazides
by: Yu. A. Azev, et al.
Published: (2020-09-01)

The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
by: Jorge Antonio Elias Godoy Carlos, et al.
Published: (2024-12-01)

EFFECTIVE METHODS OF SYNTHESIS OF 2-HETARYL[1,2,4]-TRIAZOLO[1,5-с]QUINAZOLIN-5(6H)-ONES AND ITS ANTIBACTERIAL ACTIVITY
by: A. K. Bilyi, et al.
Published: (2013-12-01)

Evaluation of Quinazolin-2,4-Dione Derivatives as Promising Antibacterial Agents: Synthesis, In Vitro, In Silico ADMET and Molecular Docking Approaches
by: Aboubakr H. Abdelmonsef, et al.
Published: (2024-11-01)

Determination of the Anti-Escherichial Activity of the Pyrimidine Derivative 3-[2-[(4,6-dimethylpyrimidin-2- yl)amino]-2-oxoethyl]quinazolin-4(3H)-one
by: A. A. Tsibizova, et al.
Published: (2023-12-01)

Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones
by: O. S. Kolomoets, et al.
Published: (2016-12-01)

Integrating One Health: Beyond buzzwords and silos
by: Andrea Antoniolli, et al.
Published: (2025-12-01)

A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
by: Fatemeh Yousefbeyk, et al.
Published: (2025-01-01)

NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
by: Gustavo Nery de Queiroz, et al.
Published: (2024-12-01)

Carboxyl-containing quinazolines and related heterocycles as carriers of anti-inflammatory activity
by: N. I. Krasovska, et al.
Published: (2022-02-01)